About Us

The Section of Gastroenterology and Hepatology in the Department of Medicine specializes in the medical education, research and the prevention, diagnosis and treatment of digestive tract and liver diseases.

Our screening and diagnostic services use the most advanced equipment for indicated procedures. We also offer several specialized centers including the Barrett's Esophagus Center, and the Inflammatory Bowel Disease Center. The Baylor College of Medicine Liver Transplant Program is one of the nation's best. 

The Section of Gastroenterology and Hepatology participates in research through the Texas Medical Center Digestive Diseases Center. The center facilitates ongoing digestive diseases research, promotes translational research between basic and clinical areas, develops new projects, nurtures new investigators, and provides GI educational activities.

The Section of Gastroenterology and Hepatology offers numerous opportunities for physician training at all stages from medical student education to continuing medical education. The gastroenterology fellowship training program is accredited by the American Board of Internal Medicine Subspecialties.

Several flags fly on a sunny day outside a building in the Texas Medical Center

GI and Hepatology 2018 Annual Report

This annual report outlines some of the achievements and recognition received during 2018.

AGA Congressional Advocates Program Meeting with Jay Guerrero (372x158)

AGA Congressional Advocates Program meeting

Faculty members met with Senator John Cornyn's regional director for Southeast Texas, Jay Guerrero, to discuss NIH funding, the Restoring the Patient’s Voice Act, the Removing Barriers to Colorectal Cancer Screening Act of 2018, and the colonoscopy “loophole.” Learn more in an article the participants wrote.

Fasiha Kanwal, M.D., MSHS (372x158)

National Cancer Institute Funding

Dr. Fasiha Kanwal received funding from the NCI for her U01 grant entitled, "Risk Stratification for and Early Detection of Liver Cancer." The study's goal is to reduce the mortality of hepatocellular cancer by developing personalized indices that combine novel and existing biomarkers with clinical, behavioral and genetic data to improve clinical risk stratification and increase early detection.  

Graphic rendering of a man's internal organs, featuring the gastrointestinal tract

NIH renews grant to advance digestive disease research

A National Institutes of Health grant is a commitment to continue the impactful work being done through the Texas Medical Center Digestive Diseases Center.